FDA granted accelerated approval to umbralisib / HPBCD tablet
The Food and Drug Administration granted accelerated approval to umbralisib (Ukoniq, TG Therapeutics), a kinase inhibitor including PI3K-delta and casein
Author: István Puskás
research chemist
HPBCD is a unique component in Janssen’s COVID-19 vaccine candidate
Amongst Janssen’s novel single-dose Covid-19 vaccine candidate of adenovirus platform excipients one might notice a peculiar compound: Hydroxypropyl Betadex (HPBCD).
Successful use of SBECD as vehicle in intravitreal treatment
A retrospective study based on data collected from Memorial Sloan-Kettering Cancer Center, New York shows high efficacy and low toxicity
Use of sulfobutylether beta cyclodextrin for preparing ceramics
A very few patent applications may trace back prior art disclosure to the Neolithic Age (from 10000 – 4500 BC)
500th post in Cyclodextrin News blog
1986, the year of the first issue of Cyclodextrin News was abundant in notable events and new threats to be
Ozone storage in solid form by cyclodextrins
A French research consortium (Institut National Polytechnique de Toulouse, Ecole D’ingenieurs de Purpan, Universite Paul Sabatier Toulouse, Centre National de
Methyl BCD for axon regeneration after injury – PNAS cover paper
The cover paper of PNAS (1) presents a concept for promoting the neuronal regenerative potential by engineering the expression of
37th Japanese National Cyclodextrin Symposium postponed
The 37th Japanese National Cyclodextrin Symposium (planned to be held between Sept. 3-4, 2020 at Osaka University) will be postponed
Use of cyclodextrins as agrochemical delivery system
ADAMA MAKHTESHIM LTD. (Israel) filed a PCT patent application (WO2020084572) that was recently published. The invention relates to preparation and use
Use of SBECD in kit containing contact lens storage solution
Use of cyclodextrins in contact lens cleaning solutions is dating back to almost thirty years. A patent application was filed